Earnings · China A-shares
Zhejiang Shengda Bio-Pharm Co., Ltd. Class A (603079) earnings
Zhejiang Shengda Bio-Pharm Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -52.91% year on year, -53.36% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -6.38% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -52.91%
- Excl. one-offs YoY
- -53.36%
- Net profit QoQ
- -37.56%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.09% | — |
| 3 days | -6.38% | — |
| 7 days | -0.94% | — |
| 14 days | -4.85% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -2.14%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥25.12M | -52.91% | -53.36% | -4.54% | 0.13 | 1.58% | -6.38% | — | — |
| 2026 interim report | 2026-08-28 | ¥20.53M | -45.70% | -46.03% | -2.91% | 0.11 | 1.29% | -1.89% | -9.32% | +0.37% |
| 2026 Q1 report | 2026-04-27 | ¥13.17M | -39.31% | -38.75% | -6.89% | 0.07 | 0.83% | -6.24% | -25.06% | -24.76% |
| 2025 annual report | 2026-04-27 | ¥62.16M | +111.24% | +149.79% | +2.07% | 0.35 | 4.37% | -6.24% | -25.06% | -24.76% |
| 2025 Q3 report | 2025-10-30 | ¥53.34M | +146.04% | +393.96% | +2.04% | 0.30 | 3.88% | +0.49% | -4.60% | +0.15% |
| 2025 interim report | 2025-08-26 | ¥37.81M | +129.20% | +580.57% | +4.23% | 0.22 | 2.95% | -3.51% | -5.18% | -6.86% |
| 2025 Q1 report | 2025-04-28 | ¥21.71M | +469.35% | +1749.87% | +9.95% | 0.13 | 1.71% | +4.72% | +4.03% | +0.78% |
| 2024 annual report | 2025-04-28 | ¥29.42M | +154.43% | +136.10% | +13.75% | 0.17 | 2.35% | +4.72% | +4.03% | +0.78% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.